James Vaughn
2018
In 2018, James Vaughn earned a total compensation of $1.6M as Chief U.S. Commercial Officer at Genomic Health, a 12% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $258,780 |
---|---|
Option Awards | $662,011 |
Salary | $416,200 |
Stock Awards | $225,496 |
Total | $1,562,487 |
Vaughn received $662K in option awards, accounting for 42% of the total pay in 2018.
Vaughn also received $258.8K in non-equity incentive plan, $416.2K in salary and $225.5K in stock awards.
Rankings
In 2018, James Vaughn's compensation ranked 6,960th out of 14,244 executives tracked by ExecPay. In other words, Vaughn earned more than 51.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,960 | 51st |
Services | 1,320 | 45th |
Health Services | 103 | 53rd |
Medical And Dental Laboratories | 22 | 71st |
Medical Laboratories | 22 | 71st |
Vaughn's colleagues
We found four more compensation records of executives who worked with James Vaughn at Genomic Health in 2018.